Agapi Parcharidou

1.5k total citations
20 papers, 1.0k citations indexed

About

Agapi Parcharidou is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Agapi Parcharidou has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 9 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Agapi Parcharidou's work include Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (7 papers) and Cancer Treatment and Pharmacology (3 papers). Agapi Parcharidou is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (7 papers) and Cancer Treatment and Pharmacology (3 papers). Agapi Parcharidou collaborates with scholars based in Greece, United States and United Kingdom. Agapi Parcharidou's co-authors include Azra Raza, Suneel Mundle, Sefer Gezer, Raphael Borok, S. Alvi, Amna Iftikhar, S. Rifkin, V. Shetty, Zafiris Kartasis and Argiris Symeonidis and has published in prestigious journals such as Blood, PEDIATRICS and Annals of Oncology.

In The Last Decade

Agapi Parcharidou

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Agapi Parcharidou Greece 13 782 450 242 199 160 20 1.0k
Marianna Criscuolo Italy 21 481 0.6× 295 0.7× 194 0.8× 233 1.2× 112 0.7× 72 1.0k
Thomas Stübig Germany 15 573 0.7× 268 0.6× 197 0.8× 242 1.2× 177 1.1× 25 792
Richard E. Helmer United States 6 851 1.1× 694 1.5× 140 0.6× 269 1.4× 86 0.5× 9 1.3k
M Gyger Canada 19 712 0.9× 241 0.5× 219 0.9× 170 0.9× 447 2.8× 56 1.2k
Lisa Pleyer Austria 18 435 0.6× 369 0.8× 248 1.0× 309 1.6× 204 1.3× 53 947
Estelle Verburgh South Africa 10 447 0.6× 437 1.0× 100 0.4× 227 1.1× 52 0.3× 35 824
Valérie Mialou France 12 407 0.5× 228 0.5× 191 0.8× 113 0.6× 190 1.2× 45 912
A. M. Stoppa France 17 1.2k 1.5× 440 1.0× 317 1.3× 211 1.1× 362 2.3× 34 1.5k
Hakumei Oh Japan 8 849 1.1× 363 0.8× 305 1.3× 221 1.1× 64 0.4× 15 1.1k
DC Young United States 10 531 0.7× 295 0.7× 232 1.0× 118 0.6× 375 2.3× 11 981

Countries citing papers authored by Agapi Parcharidou

Since Specialization
Citations

This map shows the geographic impact of Agapi Parcharidou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agapi Parcharidou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agapi Parcharidou more than expected).

Fields of papers citing papers by Agapi Parcharidou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agapi Parcharidou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agapi Parcharidou. The network helps show where Agapi Parcharidou may publish in the future.

Co-authorship network of co-authors of Agapi Parcharidou

This figure shows the co-authorship network connecting the top 25 collaborators of Agapi Parcharidou. A scholar is included among the top collaborators of Agapi Parcharidou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agapi Parcharidou. Agapi Parcharidou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ogembo, Javier Gordon, Lori W. McGinnes, Agapi Parcharidou, et al.. (2015). A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice. Journal of Translational Medicine. 13(1). 50–50. 51 indexed citations
4.
Dimopoulos, Meletios Α., Sosana Delimpasi, Eirini Katodritou, et al.. (2013). Significant improvement in the survival of patients with multiple myeloma presenting with severe renal impairment after the introduction of novel agents. Annals of Oncology. 25(1). 195–200. 109 indexed citations
5.
Dimopoulos, Meletios Α., Sosana Delimpasi, Eirini Katodritou, et al.. (2012). Significant Improvement of the Survival of Patients with Multiple Myeloma Presenting with Severe Renal Impairment After the Introduction of Novel Agents. Blood. 120(21). 948–948. 1 indexed citations
6.
Dimopoulos, Meletios Α., Efstathios Kastritis, Sossana Delimpasi, et al.. (2012). Multiple myeloma in octogenarians: Clinical features and outcome in the novel agent era. European Journal Of Haematology. 89(1). 10–15. 27 indexed citations
7.
Dimopoulos, Meletios Α., Efstathios Kastritis, Eurydiki Michalis, et al.. (2011). The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients’ renal function. Annals of Oncology. 23(3). 722–729. 19 indexed citations
8.
Kastritis, Efstathios, Eirini Katodritou, Anastasia Pouli, et al.. (2011). Frequency and Prognostic Significance of Hypercalcemia in Patients with Multiple Myeloma: An Analysis of the Database of the Greek Myeloma Study Group. Blood. 118(21). 5083–5083. 5 indexed citations
9.
Terpos, Evangelos, Eirini Katodritou, Μαρία Ρούσσου, et al.. (2010). High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents. European Journal Of Haematology. 85(2). 114–119. 102 indexed citations
10.
Papaevangelou, Vassiliki, Vassilios Papadakis, Aglaia Zellos, et al.. (2010). HEPATITIS C TREATMENT CONCOMITANT TO CHEMOTHERAPY AS “SALVAGE” THERAPY IN CHILDREN WITH HEMATOLOGIC MALIGNANCIES. The Pediatric Infectious Disease Journal. 29(3). 277–280. 4 indexed citations
11.
Dimopoulos, Meletios Α., Efstathios Kastritis, Μαρία Ρούσσου, et al.. (2010). Elevated Serum Lactate Dehydrogenase (LDH) Should Be Included Among the Variables Which Define High Risk Multiple myeloma. Blood. 116(21). 2969–2969. 6 indexed citations
12.
Galanopoulos, Athanasios, Agapi Parcharidou, Krinio Giannikou, et al.. (2009). Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndrome associated with chromosome 5q deletion. Haematologica. 95(3). 406–414. 36 indexed citations
13.
Crescenzi, Barbara, Roberta La Starza, Constantina Sambani, et al.. (2008). Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome. British Journal of Haematology. 144(1). 116–119. 15 indexed citations
14.
Papadhimitriou, Stefanos I., Georgios Paterakis, Agapi Parcharidou, et al.. (2008). TEL/AML1+ ACUTE LYMPHOBLASTIC LEUKEMIA IN THE GREEK PEDIATRIC POPULATION. PEDIATRICS. 121(Supplement_2). S111–S112. 3 indexed citations
15.
Miyakis, Spiros, et al.. (2006). INVASIVE ACREMONIUM STRICTUM INFECTION IN A BONE MARROW TRANSPLANT RECIPIENT. The Pediatric Infectious Disease Journal. 25(3). 273–275. 31 indexed citations
16.
Papadakis, Vassilios, A. Pangalis, Agapi Parcharidou, et al.. (2005). Infections in a pediatric patient cohort with acute lymphoblastic leukemia during the entire course of treatment. Supportive Care in Cancer. 14(3). 277–284. 48 indexed citations
17.
Parcharidou, Agapi, Theofanis Economopoulos, E. Papageorgiou, et al.. (1999). Extensive apoptosis of bone marrow cells as evaluated by the in situ end‐labelling (ISEL) technique may be the basis for ineffective haematopoiesis in patients with myelodysplastic syndromes. European Journal Of Haematology. 62(1). 19–26. 32 indexed citations
18.
Raza, Azra, Sairah Alvi, Lambert F. R. Span, et al.. (1997). Excessive Proliferation Matched by Excessive Apoptosis in Myelodysplastic Syndromes: The Cause-Effect Relationship. Leukemia & lymphoma. 27(1-2). 111–118. 46 indexed citations
19.
Shetty, Vilasini, Suneel Mundle, Sairah Alvi, et al.. (1996). Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leukemia Research. 20(11-12). 891–900. 156 indexed citations
20.
Raza, Azra, Sefer Gezer, Suneel Mundle, et al.. (1995). Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes [see comments]. Blood. 86(1). 268–276. 356 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marianna Criscuolo Breakdown of academic impact, for papers by Thomas Stübig Breakdown of academic impact, for papers by Richard E. Helmer Breakdown of academic impact, for papers by M Gyger Breakdown of academic impact, for papers by Lisa Pleyer Breakdown of academic impact, for papers by Estelle Verburgh Breakdown of academic impact, for papers by Valérie Mialou Breakdown of academic impact, for papers by A. M. Stoppa Breakdown of academic impact, for papers by Hakumei Oh Breakdown of academic impact, for papers by DC Young
Rankless by CCL
2026